Cue Biopharma, Inc. (CUE) vs Entrada Therapeutics, Inc. (TRDA)
Cue Biopharma, Inc. and Entrada Therapeutics, Inc. are both Biotechnology companies. Cue Biopharma, Inc. and Entrada Therapeutics, Inc. are of similar size ($242.2M and $238.6M). Cue Biopharma, Inc. grew revenue faster over the last twelve months: 354.4% against −94.1%. Cue Biopharma, Inc. has the higher net margin (−435.8% vs −3,537.7%) and the higher return on invested capital (0.00% vs −1,060.2%). Across the 15 metrics below, Cue Biopharma, Inc. leads on 10 and Entrada Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CUE | TRDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (262.03%) | (3,767.07%) | 0.00% |
| Net margin | (435.83%) | (3,537.73%) | 0.00% |
| Free cash flow margin | (133.13%) | (2,867.07%) | 0.00% |
| Return on equity | (1,603.48%) | (54.09%) | (57.72%) |
| Return on assets | (459.60%) | (44.35%) | (49.22%) |
| Return on invested capital | 0.00% | (1,060.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack